Sugar gap may reveal hidden danger in ICU patients

NCT ID NCT07240103

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 140 critically ill ICU patients to see if the difference between glucose levels in the blood and in the fluid just under the skin (interstitial fluid) can help predict death risk and metabolic problems. Researchers measured this gap and compared it to energy use, organ function, and survival. The goal is to find a simpler, less invasive way to monitor metabolism in very sick patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could give doctors a simple, minimally invasive way to monitor metabolism and predict outcomes in ICU patients.

What could go wrong

This is a small, completed observational study, not a treatment trial. The findings may not apply to all ICU patients or lead to changes in care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness Insulin Resistance metabolic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, 210000, China